FDA Import Refusal AEK-9687396-1/10002/1 — CIPLA LTD
The FDA refused shipment AEK-9687396-1/10002/1 from CIPLA LTD (India) on Aug 25, 2026. The refused product falls under Drugs and Biologics — RIFAXIMIN (A-BACTERIAL PT. I) (NOT ANTIBIOTIC). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Aug 25, 2026
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 61FCY63 RIFAXIMIN (A-BACTERIAL PT. I) (NOT ANTIBIOTIC)
- Charges
- 75